Since increased expression of MGL ligands is used to discriminate healthy from colorectal cancer (CRC) tissues, and is an independent prognostic marker for CRC stage III patients with lower disease-free survival [15], we recently investigated the identity of cell surface MGL-binding proteins on CRC cells lines [16]. The gene discussed is CLEC10A; the disease is colorectal cancer.